The Leading Ketamine Treatment Provider in Alexandria, VA
Twenty-three years of developing targeted ketamine treatment and progressive therapies for depression and pain.
Dr. Sendi has been administering ketamine for over 22 years in the Emergency Department as well as in an office setting, for which he has administered ketamine to numerous patients for the successful treatment of pain and mood disorders. His experience is extensive in the use of ketamine, and in the office environment, you can be assured that his medical experience will provide you with a comfortable and safe therapy.
Dr. Sendi is also Board Certified in Internal Medicine, Emergency Medicine, Addiction Medicine, Obesity Medicine, and Pain Management. He adds his expertise in these areas to your care so he can evaluate the root causes of your conditions and not just treat symptoms. Dr. Sendi recognized the impact of lifestyle and genetics on health as he practiced in an Emergency Department setting over the past 23 years.
With the obesity epidemic, addiction epidemic, and mental health crisis, Dr. Sendi saw the unfulfilled needs in the treatment of each of these areas. Depression, PTSD, anxiety disorders, fibromyalgia, chronic fatigue, and many other disorders have root causes that include diet, exercise, lifestyle, and genetics, each of which can be treated to improve mood, energy, and act as an anti-aging strategy. Don’t be cheated out of your health by not exploring all the options.
Conditions Ketamine Can Help Treat
Depression is the leading cause of disability in people between the ages of 15 –44. Major depression is a common debilitating disorder affecting 10%–15% of the population per year. Despite advances in the understanding of the psychopharmacology and biomarkers of major depression and the introduction of several novel classes of antidepressants, only 60%–70% of patients with depression respond to antidepressant therapy.
Of those who do not respond, 10%–30% exhibit treatment-resistant symptoms coupled with difficulties in social and occupational function, a decline in physical health, suicidal thoughts, and increased health care utilization. According to the findings from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) study, 50%–66% of patients with depression do not recover fully on antidepressant medication and one-third of patients do have a remission of their depressive symptoms.
Scientists think that in people with clinical depression, certain neurotransmitters may be out of balance. One option for treating depression is prescription drugs that affect the levels of certain chemicals that brain cells use to communicate, called neurotransmitters. These options are sometimes called antidepressant medications. Some types of antidepressant medications that are available include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and tricyclic antidepressants (TCAs), and monoamine oxidase inhibitors (MAOIs).
These medications affect levels of serotonin, among other neurotransmitters to produce their effect. Other options for treatment include psychotherapy, Transcranial Magnetic Stimulation (TMS), and ECT (Electroconvulsive therapy).
Despite these advances, many therapies do not work well in a significant percentage of the population and produce their effectiveness very slowly. In a landmark 2000 study published in Biological Psychiatry, Robert Berman and colleagues at the Yale School of Medicine demonstrated that ketamine had quick-action antidepressant properties on people with treatment-resistant depression.
Further investigations by Carlos Zarate showed that a single infusion of ketamine produced robust improvement in depression in 71% of the test subjects and remission in 29%. Further work by Carlos Zarate using was showcased in the JAMA 2017 article in which the ketamine experience of rapid antidepressant effects was reviewed in an interview.
Ketamine has produced rapid reductions in depression in treatment-refractory patients in numerous studies and has performed well when other interventions had minimal impact. This has been experienced in our ketamine center as well. For more information, links to ketamine in the media are available to download:
Are You Ready To Start Living Life On Your Terms Again?